MS: Busting the Myths
February 25, 2025 | Advocacy, Carer, Carers, Event, Funding, Life with MS, News, Survey
Consultation is underway across the country to help shape future disability funding and service models. This is your opportunity to have your say and we encourage you to do so, now more than ever. Note: This consultation is for people […]
February 24, 2025 | Advocacy, News
Recently, Multiple Sclerosis New Zealand (MSNZ) wrote to Pharmac to express our immense disappointment with their Health Technologies Assessment (HTA) process, the treatment funding assessment process, and the impact this is having on the MS community. The varicella zoster virus, […]
October 15, 2024 | Media, News, Press Release, Progressive
Pharmac’s decision-making process for funding drugs in Aotearoa New Zealand is in need of a major overhaul – according to a new independent report. The Milne Report, commissioned by Multiple Sclerosis New Zealand (MSNZ), says its time Pharmac based its […]
May 30, 2024 | Advocacy, Treatments
At MSNZ we would like to understand more about patient experiences with infusion treatments. The first line Disease Modifying Treatment (DMT) options we have been successful in advocating for in NZ are considered some of the best in the world. […]
April 30, 2024 | Advocacy, Funding, Life with MS
On Monday 18 March 2024, Whaikaha – Ministry of Disabled People, announced changes to the purchasing rules for Carer Support, Individualised Funding, Enhanced Individualised Funding, personal budgets, and Choices in Community Living. On 24 April, following significant feedback from the […]